Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Shenzhen Stock Exchange 300760.SZ

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 66.16%

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Gross Profit Margin is 66.16% for the year ending December 31, 2023, a 3.13% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 64.15%, a -1.31% change year over year.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 65.01%, a 0.06% change year over year.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 64.97%, a -0.42% change year over year.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 65.24%, a -2.00% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
Shenzhen Stock Exchange: 300760.SZ

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

CEO Mr. Hao Wu
IPO Date Oct. 16, 2018
Location China
Headquarters Mindray Building
Employees 18,044
Sector Health Care
Industries
Description

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.

StockViz Staff

January 15, 2025

Any question? Send us an email